FSL-1: A Synthetic Peptide Increases Survival in a Murine Model of Hematopoietic Acute Radiation Syndrome.

MLA

Holmes-Hampton, Gregory P., et al. “FSL-1: A Synthetic Peptide Increases Survival in a Murine Model of Hematopoietic Acute Radiation Syndrome.” Radiation Research, vol. 201, no. 5, May 2024, pp. 449–59. EBSCOhost, https://doi.org/10.1667/RADE-23-00142.1.

APA

Holmes-Hampton, G. P., Kumar, V. P., Valenzia, K., & Ghosh, S. P. (2024). FSL-1: A Synthetic Peptide Increases Survival in a Murine Model of Hematopoietic Acute Radiation Syndrome. Radiation Research, 201(5), 449–459. https://doi.org/10.1667/RADE-23-00142.1

Chicago

Holmes-Hampton, Gregory P, Vidya P Kumar, Kaylee Valenzia, and Sanchita P Ghosh. 2024. “FSL-1: A Synthetic Peptide Increases Survival in a Murine Model of Hematopoietic Acute Radiation Syndrome.” Radiation Research 201 (5): 449–59. doi:10.1667/RADE-23-00142.1.